Position in PRGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,346,226
+$335,426 QoQ
Shares Held
125,347
+72.6% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bridgewater Associates, LP holds $156,606,653 across 13 Drug Manufacturers - Specialty & Generic names. PRGO ranks #11 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
111,169 | $65,920,993 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,128,406 | $33,987,588 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
148,141 | $19,516,095 | |
| 4 | VTRS |
Viatris Inc
|
725,884 | $9,806,692 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
638,054 | $6,074,274 | |
| 6 | ZTS |
Zoetis Inc.
|
50,739 | $5,997,857 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
670,366 | $3,619,976 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
43,720 | $3,316,162 |
All Filings in PRGO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,346,226 | 125,347 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,010,800 | 72,615 | Shares | Sole | 2026-02-13 | |
| 2024-09-30 | $557,859 | 21,268 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,005,911 | 39,171 | Shares | Sole | 2024-08-14 | |
| 2021-09-30 | $1,480,151 | 31,273 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,417,773 | 30,922 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $275,074 | 5,720 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||